Wednesday, 13 July 2022
A new type of dressing for post-surgical treatment of melanoma has been created by scientists who have discovered a new method for making a material that can kill cancer cells and simultaneously regenerate healthy ones.
Scientists from the 糖心原创 have combined graphene oxide, elastin, and ethanol to develop a new method to make this material conductive so it can be heated to kill melanoma cells but not other cells around it. The research has been published in
Surgical resection (the process of removing a piece of tissue) is a common treatment for skin melanoma but can lead to post-operative recurrence, which can need further surgery plus chemotherapy and radiotherapy. It can also be hard to treat due to tumour cells often developing resistance to treatments. The use of Photothermal Therapy (PTT), which relies on conductive materials that can convert light into heat to kill cancer cells, is being explored as a new treatment and this new research demonstrates how this could be applied using a dressing with minimal exposure to light needed.
Graphene oxide (GO) offers the possibility to be integrated with other materials such as proteins and the team has used this approach to assemble thin GO-elastin membranes that promote cell growth. However, GO is not conductive enough. Making it conductive usually requires harsh processes and high temperatures of over 140 °C that limits its use. In this study, the researchers developed an innovative method to make GO conductive in an efficient manner but requiring lower temperatures (85 °C). This process enabled the fabrication of GO-elastin materials that are conductive and can promote the growth of immune boosting endothelial cells to promote regeneration and healing.
Using this method, dressings have been created that only need to be heated using Near Infrared light (NIR) for 15 seconds every 48 hours to be effective. NIR is currently used for some skin treatments and can be delivered by the patient at home. The addition of the ethanol in the dressing means it is also sterile, promoting healing and reducing the risk of infection.
We know that graphene oxide (GO)-protein materials offer huge potential for biomedical devices but the need for harsh processes to make graphene oxide conductive at high temperatures has limited their use. Our new method offers a solution to this, enabling the fabrication of protein-based materials with both efficient photothermal conductivity and bioactive properties. These materials could be used as dressings for post-surgery treatment and healing of skin cancer, operating within a narrow temperature window where 鈥渂ad鈥� cells are killed and 鈥済ood鈥� cells are not.
Dr Yuanhao Wu, a biomedical engineer and plastic surgeon who led the study said: “Given the aggressive nature of melanoma, surgical resections to remove it have to be significantly larger than the size of the tumours to minimize the presence of residual cells. This creates a new wound and delays healing. Beyond the prevention of tumour recurrence and promotion of tissue healing, our dressings could also lead to smaller surgical resections and practical post-surgery treatments that are non-invasive and could be delivered at home."
Story credits
More information is available from Professor Alvaro Mata at Alvaro.mata@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.